Clinical Trial Update: Action to Control Cardiovascular Risk in Diabetes (ACCORD) [Phase 3]

View source ↗

Summary

Phase 3 ACCORD trial evaluating strategies to reduce cardiovascular risk in people with diabetes; results were posted in 2014. The study investigated intensive …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Disease
• Coronary Artery Disease
• Hypercholesterolemia
• Hypertension
• Type 2 Diabetes Mellitus

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Atherosclerosis, Cardiovascular Diseases | Phase 3 | Status: COMPLETED | Results posted: 2014-09-15